Saturn V Capital Management LP 13D and 13G filings for KalVista Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-12 8:30 pm Purchase | 2023-12-31 | 13G | KalVista Pharmaceuticals, Inc. KALV | Saturn V Capital Management LP | 1,431,259 4.100% | 1,431,259 (New Position) | Filing |